gabexate and diminazene

gabexate has been researched along with diminazene in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Drakoulis, N; Ion, GND; Moschos, SA; Nikolouzakis, TK; Nitulescu, G; Nitulescu, GM; Paunescu, H; Petrakis, D; Spandidos, DA; Tsatsakis, A1
Barygin, OI; Tikhonov, DB; Zhigulin, AS1

Reviews

1 review(s) available for gabexate and diminazene

ArticleYear
Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).
    International journal of molecular medicine, 2020, Volume: 46, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Betacoronavirus; Bromhexine; Chlorpromazine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Diminazene; Drug Repositioning; Esters; Gabexate; Guanidines; Humans; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Recombinant Proteins; SARS-CoV-2; Signal Transduction; Virus Internalization

2020

Other Studies

1 other study(ies) available for gabexate and diminazene

ArticleYear
Mechanisms of acid-sensing ion channels inhibition by nafamostat, sepimostat and diminazene.
    European journal of pharmacology, 2023, Jan-05, Volume: 938

    Topics: Acid Sensing Ion Channels; Animals; Diminazene; Gabexate; Guanidines; Hydrogen-Ion Concentration; Rats

2023